Compare MLSS & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLSS | ALGS |
|---|---|---|
| Founded | 1989 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2M | 34.6M |
| IPO Year | 1996 | 2020 |
| Metric | MLSS | ALGS |
|---|---|---|
| Price | $0.30 | $2.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $1.25 | ★ $36.88 |
| AVG Volume (30 Days) | ★ 97.5K | 59.4K |
| Earning Date | 11-12-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.30 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,973,982.00 | $2,186,000.00 |
| Revenue This Year | $11.14 | $1,433.30 |
| Revenue Next Year | $13.80 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.99 | N/A |
| 52 Week Low | $0.22 | $1.92 |
| 52 Week High | $0.58 | $13.69 |
| Indicator | MLSS | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 42.11 | 22.28 |
| Support Level | $0.30 | N/A |
| Resistance Level | $0.31 | $7.79 |
| Average True Range (ATR) | 0.03 | 0.53 |
| MACD | 0.00 | -0.29 |
| Stochastic Oscillator | 23.08 | 7.24 |
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.